Frequency Therapeutics, Inc.
19 Presidential Way, 2nd Floor
Woburn, MA 01801
November 20, 2020
VIA EDGAR TRANSMISSION
Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 4720
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tim Buchmiller
FREQUENCY THERAPEUTICS, INC.
Registration Statement on Form S-3 (Registration No. 333-250099)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (Registration No. 333-250099) (the Registration Statement) of Frequency Therapeutics, Inc. (the Company). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern Time, on November 24, 2020, or at such later time as the Company or its counsel may orally request via telephone call to the staff. Please contact Nathan Ajiashvili of Latham & Watkins LLP, counsel to the Company, at (212) 906-2916, or in his absence, Jennifer Yoon at (617) 880-4540, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
Very truly yours,
|FREQUENCY THERAPEUTICS, INC.|
Name: Michael D. Bookman
Title: Deputy General Counsel
David L. Lucchino., Frequency Therapeutics, Inc.
John Chory, Esq., Latham & Watkins LLP
Nathan Ajiashvili, Esq., Latham & Watkins LLP
Jennifer A. Yoon, Esq., Latham & Watkins LLP